Arpida | Evaluate

August 14, 2015

Interview – Motif seizes on antibiotic renaissance

December 10, 2010

Event - Evolva lockup expiry will unleash volatility

January 11, 2010

Evolva share surge prompts head scratching

September 14, 2009

Theravance approval does little to ignite shares

June 03, 2009

Advanced Life Sciences reeling from FDA rejection

January 09, 2009

Emergent tops slim list of stock market winners for 2008

November 28, 2008

Companies desperate for a partner

November 27, 2008

One-product companies currently on a knife edge

November 27, 2008

Therapeutic focus - recent antibiotic setbacks disappointing for already slow field

November 21, 2008

Basilea's antibiotic left looking like strongest candidate

November 20, 2008

Event - Targanta and Theravance face short wait for final FDA decisions

Load More